Cavitron? and CAVASOL* hydroxypropyl-?- and hydroxypropyl-γ-cyclodextrins (HPBCD and HPGCD)

Chemistry: Cyclodextrins

SDS Link >

The molecular structure of cyclodextrins creates a bucket-like cavity that can function to complex with molecules or functional groups on molecules. The substitution of hydroxyl groups on native cyclodextrins to make hydroxypropyl-?- or hydroxypropyl-γ-cyclodextrins (HPBCD or HBGCD) significantly enhances their solubility and makes them more suitable for drug solubilization. This mechanism makes the Cavitron and CAVASOL HPBCDs and HPGCDs capable of masking unpleasant taste/odor and stabilizing drugs that are prone to degradation, and also can increase solubility of poorly soluble compounds in oral drug delivery systems. Purification of the Cavitron cyclodextrins to remove endotoxins allows their use for solubilization of drugs for parenteral drug products.

The regulatory compliance information for all Ashland products varies by product family and grade. For specific data about the grade you are interested in please refer to our Excipient Information Package, now called PRD, and the Certificate of Analysis (COA).

*CAVASOL is a registered trademark owned by Wacker Chemie AG. Ashland Inc. acts as a worldwide distributor for Wacker.

Questions? Sample request?

Contact a solver today. 

Read More >

韩国快乐8投注平台
福彩开奖直播 河北20选走势图 喊21的游戏规则 天天棋牌龙虎技巧 线上德州扑克平台哪个好 上海快3计划软件下载 nba全明星赛下载 三星杀号计划 棒球规则教学 单双中特资料验证区 188比分直播 福彩快三网站 温州游戏棋牌 三张牌炸金花怎么能赢 28号湖南幸运赛车开奖结果